Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarshalls Regulatory News (MSLH)

Share Price Information for Marshalls (MSLH)

Share Price is delayed by 15 minutes
Get Live Data
142.30    0.50 (0.35%)
Bid:
142.50
Ask:
142.90
Spread: 0.40 (0.281%)
Market Cap: £359.86m
MSLH Live PriceLast checked at - London Stock Exchange

Intraday Marshalls Share Chart

Directorate Change

28 Apr 2010 09:44

RNS Number : 9339K
Marshalls PLC
28 April 2010
Β 

ο»Ώ

Β 

28 April 2010

Β 

APPOINTMENT OF NON-EXECUTIVE DIRECTORS

Β 

Marshalls plc announces the appointment of two new non-executive directors, Alan Coppin and Mark Edwards, to take effect immediately after the next Annual General Meeting of Marshalls plc on 12 May 2010. This announcement includes the information required by Listing Rules 9.6.11 to 9.6.13.

Β 

Alan Coppin is a non-executive director of Berkeley Group Holdings plc and Capital and Regional Plc, and was previously Chairman of Redstone Plc and a director of Carillion plc. Between 1988 and 1998 he was Chief Executive of Wembley plc, and subsequently Chief Executive of the Global Operating Division of Compass plc. He is also a non-executive director of the Royal Air Force and a patron of the Windsor Leadership Trust. He has wide experience in both governance and management, with particular focus on marketing and the leisure industry.

Β 

Mark Edwards is a chartered accountant with extensive experience in the manufacturing sector, most recently as Chief Executive of Baxi Group. He was formerly Finance Director of the Security and Building Products Division of Williams plc, and has held a number of other senior finance positions. He was a director of Heating Finance plc between 2004 and 2008. He is also a former Vice President of the Construction Products Association.

Β 

Richard Scholes, who has served on the Board since 2003, will be stepping down from the Board immediately after the 2010 Annual General Meeting. Alan Coppin is expected to succeed Richard Scholes as Senior Independent Director and will also chair the Remuneration Committee. Mark Edwards will succeed Richard Scholes as Chairman of the Audit Committee.

Β 

Mike Davies, Chairman, commented: "The Board would like to record its thanks to Richard Scholes for his valuable contribution during his term of office. Both I and Andrew Allner, Chairman-Designate, are delighted we have been able to attract to the Board two new non-executive directors of such high calibre, and the Board is looking forward to benefiting from their extensive skills and experience".

Β 

Β 

Enquiries:

Graham Holden - Chief Executive

Andrew Allner - Chairman-Designate

Telephone number: 01484 438900

Β 

Β 

Jon Coles - Brunswick

Telephone number: 020 7404 5959

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
BOAUWOWRRWASURR
Date   Source Headline
19th Aug 20223:36 pmRNSDirector/PDMR Shareholding
18th Aug 20227:00 amRNSHalf-year Report
3rd Aug 20224:12 pmRNSHolding(s) in Company
18th Jul 202210:04 amRNSDirector/PDMR Shareholding
14th Jul 202211:51 amRNSDirector/PDMR Shareholding
12th Jul 20227:00 amRNSTrading Statement
11th May 20221:34 pmRNSResult of AGM
11th May 20227:00 amRNSTrading Statement
10th May 20223:14 pmRNSDirector/PDMR Shareholding
10th May 20223:02 pmRNSDirector/PDMR Shareholding
5th May 20229:19 amRNSHolding(s) in Company
3rd May 20224:20 pmRNSHolding(s) in Company
3rd May 20223:09 pmRNSDirector/PDMR Shareholding
3rd May 20223:08 pmRNSDirector/PDMR Shareholding
3rd May 20223:07 pmRNSDirector/PDMR Shareholding
3rd May 20223:06 pmRNSDirector/PDMR Shareholding
3rd May 20223:03 pmRNSDirector/PDMR Shareholding
3rd May 20223:02 pmRNSDirector/PDMR Shareholding
3rd May 20223:01 pmRNSDirector/PDMR Shareholding
3rd May 20223:00 pmRNSDirector/PDMR Shareholding
3rd May 20222:57 pmRNSDirector/PDMR Shareholding
3rd May 20222:53 pmRNSDirector/PDMR Shareholding
3rd May 20229:54 amRNSHolding(s) in Company
29th Apr 20228:25 amRNSTotal Voting Rights
29th Apr 20228:05 amRNSAcquisition
28th Apr 202211:51 amRNSAcquisition
27th Apr 202210:01 amRNSDirector Declaration
7th Apr 20221:50 pmRNSPublication of Prospectus
7th Apr 20227:00 amRNSResults of Accelerated Bookbuild
6th Apr 20224:46 pmRNSProposed Acquisition of Marley Group & Fundraising
5th Apr 20228:58 amRNSAnnual Financial Report
4th Apr 20228:54 amRNSHolding(s) in Company
18th Mar 20223:44 pmRNSDirector/PDMR Shareholding
18th Mar 20223:43 pmRNSDirector/PDMR Shareholding
17th Mar 20227:15 amRNSBoard Appointment
17th Mar 20227:00 amRNSFinal Results
4th Mar 20229:48 amRNSDirector/PDMR Shareholding
4th Feb 20222:42 pmRNSDirector/PDMR Shareholding
31st Jan 202210:29 amRNSDirector Declaration
18th Jan 20227:00 amRNSTrading Statement
5th Jan 20222:31 pmRNSDirector/PDMR Shareholding
14th Dec 202111:26 amRNSDirectorate Change
6th Dec 202110:51 amRNSDirector/PDMR Shareholding
11th Nov 20212:58 pmRNSDirector/PDMR Shareholding
5th Oct 202110:32 amRNSDirector/PDMR Shareholding
1st Oct 20214:03 pmRNSDirector/PDMR Shareholding
29th Sep 20214:09 pmRNSDirector/PDMR Shareholding
21st Sep 20213:54 pmRNSDirector/PDMR Shareholding
21st Sep 20213:53 pmRNSDirector/PDMR Shareholding
7th Sep 20212:06 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.